Exclusive: U.S. drug benefit managers clamp down on specialty pharmacies

NEW YORK/LOS ANGELES (Reuters) - In recent days, the largest U.S. managers of private prescription drug benefits have cut off at least eight pharmacies that work closely with drugmakers, intensifying scrutiny of a system that helps inflate drug prices, officials at the benefit managers told Reuters.